Overview

Topiramate in the Treatment of Post Traumatic Stress Disorder (PTSD)

Status:
Completed
Trial end date:
2004-09-01
Target enrollment:
Participant gender:
Summary
To study the potential therapeutic effects of topiramate (Topamax) in the treatment of PTSD.
Phase:
Phase 4
Details
Lead Sponsor:
Tuscaloosa Research & Education Advancement Corporation
Collaborator:
Ortho-McNeil Janssen Scientific Affairs, LLC
Treatments:
Topiramate